Trial UFT/RT randomized multicenter phase II randomized trial testing ftorafur (UFT) associated with neoadjuvant radiotherapy versus radiotherapy alone in rectal adenocarcinoma

Trial Profile

Trial UFT/RT randomized multicenter phase II randomized trial testing ftorafur (UFT) associated with neoadjuvant radiotherapy versus radiotherapy alone in rectal adenocarcinoma

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2010

At a glance

  • Drugs Folinic acid; Tegafur/uracil
  • Indications Rectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms UFT-RT
  • Most Recent Events

    • 16 Jul 2009 Status changed from active, no longer recruiting to completed.
    • 02 Jun 2009 Primary endpoint results presented at the 45th Annual Meeting of the American Society of Clinical Oncology
    • 02 Jun 2009 Status change from active, no longer recruiting to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top